| scholarly article | Q13442814 |
| P50 | author | Frank J. Gonzalez | Q86888845 |
| Himanshu A Pandya | Q90743877 | ||
| Rakesh M Rawal | Q56487623 | ||
| Sivakumar Prasanth Kumar | Q56811304 | ||
| Chirag N Patel | Q61163094 | ||
| P2093 | author name string | Daxesh P Patel | |
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research | Q24530127 | ||
| Use of QSARs in international decision-making frameworks to predict health effects of chemical substances | Q24815781 | ||
| The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality | Q26998816 | ||
| Network medicine: a network-based approach to human disease | Q29547462 | ||
| Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
| Prediction of CNS activity of compound libraries using substructure analysis | Q30883319 | ||
| Chemical genomics profiling of environmental chemical modulation of human nuclear receptors | Q33890181 | ||
| Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention | Q33903066 | ||
| An active role for machine learning in drug development | Q33935909 | ||
| The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform | Q34367618 | ||
| The ToxCast program for prioritizing toxicity testing of environmental chemicals | Q34564990 | ||
| Quantitative structure-activity relationships for predicting mutagenicity and carcinogenicity | Q35201873 | ||
| Early prediction of drug metabolism and toxicity: systems biology approach and modeling | Q35666147 | ||
| Role of Pharmacovigilance in India: An overview | Q36077051 | ||
| In silico toxicology models and databases as FDA Critical Path Initiative toolkits | Q36405302 | ||
| Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization | Q36648761 | ||
| From the analyst's couch. Trends in development cycles | Q74468330 | ||
| Harmonization in the regulation of pharmaceutical research and human rights: the need to think globally | Q74652368 | ||
| A modification of the nitroprusside method of analysis for glutathione | Q75670646 | ||
| A method for the rapid determination of alkaline phosphates with five cubic millimeters of serum | Q82134081 | ||
| Systems toxicology | Q84075193 | ||
| Spectrophotometric Assay for Superoxide Dismutase Based on the Reduction of Highly Water-soluble Tetrazolium Salts by Xanthine-Xanthine Oxidase | Q87852768 | ||
| Perspectives on In Vitro to In Vivo Extrapolations | Q92345127 | ||
| Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies | Q36774623 | ||
| Improving the human hazard characterization of chemicals: a Tox21 update | Q36984065 | ||
| Computational toxicology--a state of the science mini review | Q37027100 | ||
| Computational toxicology in drug development | Q37135902 | ||
| Alzheimer's disease clinical and research update for health care practitioners | Q37180713 | ||
| Toxicology. Transforming environmental health protection | Q37185407 | ||
| Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter | Q37376544 | ||
| Alternative strategies for toxicity testing of species-specific biopharmaceuticals | Q37527451 | ||
| Neuropsychiatric symptoms in Parkinson's disease | Q37600783 | ||
| Computational toxicology--a tool for early safety evaluation | Q37616328 | ||
| A generic operational strategy to qualify translational safety biomarkers | Q37875384 | ||
| Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization | Q38418590 | ||
| Nonclinical safety testing of biopharmaceuticals--Addressing current challenges of these novel and emerging therapies. | Q38980247 | ||
| Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water | Q39122338 | ||
| The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities | Q39483161 | ||
| Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase | Q39513011 | ||
| ELISA: Enzyme-Linked Immunosorbent Assay | Q40197912 | ||
| The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines | Q41063192 | ||
| Natural products in drug discovery and development | Q41334729 | ||
| Network medicine in disease analysis and therapeutics | Q41890269 | ||
| Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests | Q41912439 | ||
| Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles by liver microsomes: interspecies differences and structure-metabolism relationships | Q44135058 | ||
| The 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay as rapid colorimetric method for determination of antibiotic susceptibility of clinical Mycobacterium tuberculosis isolates in liquid medium. | Q44543084 | ||
| The target landscape of clinical kinase drugs | Q47345032 | ||
| ADVERPred-Web Service for Prediction of Adverse Effects of Drugs. | Q47366719 | ||
| A toxicity evaluation and predictive system based on neural networks and wavelets | Q48275343 | ||
| Self-organizing neural projections | Q48496933 | ||
| Modeling blood-brain barrier partitioning using the electrotopological state | Q48567415 | ||
| Use of toxicological information in drug design | Q48623791 | ||
| In silico prediction of blood brain barrier permeability: an Artificial Neural Network model. | Q48680746 | ||
| Toxicology and Biodistribution: The Clinical Value of Animal Biodistribution Studies. | Q52654942 | ||
| The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. | Q53135035 | ||
| Distribution of adenosinetriphosphatase activity in ram and bull spermatozoa. | Q53745931 | ||
| Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives | Q64078667 | ||
| Improved determination of total serum lipids by the sulfo-phospho-vanillin reaction | Q70403772 | ||
| A modified spectrophotometric assay of superoxide dismutase | Q70646496 | ||
| Purification and Subunit Structure of Glutathione Reductase from Bakers' Yeast | Q72023525 | ||
| A new method for the direct determination of serum cholesterol | Q73102142 | ||
| A simple method for assaying adenosine triphosphate and adenosine diphosphate in mixtures | Q74025206 | ||
| P433 | issue | 3 | |
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 159-166 | |
| P577 | publication date | 2019-10-29 | |
| P1433 | published in | Toxicology Mechanisms and Methods | Q7830408 |
| P1476 | title | A multiparametric organ toxicity predictor for drug discovery | |
| P478 | volume | 30 |
Search more.